Benchtop MRI for pharmacokinetic evaluation of two aqueous-based nano-scaled formulations of oleic acid stabilized magnetite nanocrystals

References

• Mulder WJM, Strijkers GJ, van Tilborg GAF, et al. Lipid-based nanoparticles for contrast-enhanced MRI and molecular imaging. NMR Biomed 2006;19:142–64
   PubMed Web of Science ®Google Scholar
• Rohrer M, Bauer H, Mintorovitch J, et al. Comparison of magnetic properties of MRI contrast media solutions at different magnetic field strengths. Invest Radiol 2005;40:715–24
   PubMed Web of Science ®Google Scholar
• Mornet S, Vasseur S, Grasset F, et al. Magnetic nanoparticle design for medical diagnosis and therapy. J Mater Chem 2004;14:2161–75
   Web of Science ®Google Scholar
• Papisov MI, Bogdanov A, Schaffer B, et al. Colloidal magnetic resonance contrast agents: effect of particle surface on biodistribution. J Magn Magn Mater 1993;122:383–6
   Web of Science ®Google Scholar
• Kopp AF, Laniado M, Dammann F, et al. MR imaging of the liver with Resovist: safety, efficacy, and pharmacodynamic properties. Radiology 1997;204:749–56
   PubMed Web of Science ®Google Scholar
• Lee JM, Kim CS, Youk JH, et al. Characterization of focal liver lesions with superparamagnetic iron oxide-enhanced MR imaging: value of distributional phase T1-weighted imaging. Korean J Radiol 2003;4:9–18
   PubMed Web of Science ®Google Scholar
• Hayashi K, Nakamura M, Sakamoto W, et al. Superparamagnetic nanoparticle clusters for cancer theranostics combining magnetic resonance imaging and hyperthermia treatment. Theranostics 2013;3:366–76
   PubMed Web of Science ®Google Scholar
• Will O, Purkayastha S, Chan C, et al. Diagnostic precision of nanoparticle-enhanced MRI for lymph-node metastases: a meta-analysis. Lancet Oncol 2006;7:52–60
   PubMed Web of Science ®Google Scholar
• Bonnemain B. Nanoparticles: the industrial viewpoint. Applications in diagnostic imaging. Ann Pharm Fr 2008;66:263–7
   PubMedGoogle Scholar
• Modo MMJ, Bulte JWM, eds. Molecular and cellular MR imaging. New York: CRC Press/Taylor & Francis Group, LLC; 2007:13–36
   Google Scholar
• Strijkers GJ, Mulder WJM, van Heeswijk RB, et al. Relaxivity of liposomal paramagnetic MRI contrast agents. MAGMA 2005;18:186–92
   PubMedGoogle Scholar
• Wang YXJ, Hussain SM, Krestin GP. Superparamagnetic iron oxide contrast agents: physicochemical characteristics and applications in MR imaging. Eur Radiol 2001;11:2319–31
   PubMed Web of Science ®Google Scholar
• Corot C, Robert P, Idée JM, et al. Recent advances in iron oxide nanocrystal technology for medical imaging. Adv Drug Deliv Rev 2006;58:1471–504
   PubMed Web of Science ®Google Scholar
• Yu SS, Lau CM, Thomas SN, et al. Size- and charge-dependent non-specific uptake of PEGylated nanoparticles by macrophages. Int J Nanomedicine 2012;7:799–813
   PubMed Web of Science ®Google Scholar
• Park J, An K, Hwang Y, et al. Ultra-large-scale syntheses of monodisperse nanocrystals. Nat Mater 2004;3:891–5
   PubMed Web of Science ®Google Scholar
• Dubertret B, Skourides P, Norris DJ, et al. In vivo imaging of quantum dots encapsulated in phospholipid micelles. Science 2002;298:1759–62
   PubMed Web of Science ®Google Scholar
• Shtykova EV, Huang X, Remmes N, et al. Structure and properties of iron oxide nanoparticles encapsulated by phospholipids with poly(ethylene glycol) tails. J Phys Chem C 2007;111:18078–86
   Web of Science ®Google Scholar
• Belete A, Maeder K. Novel aqueous nano-scaled formulations of oleic acid stabilized hydrophobic superparamagnetic iron oxide nanocrystals. Drug Dev Ind Pharm 2013;39:186–96
   PubMed Web of Science ®Google Scholar
• Briley-Saebo K, Bjørnerud A, Grant D, et al. Hepatic cellular distribution and degradation of iron oxide nanoparticles following single intravenous injection in rats: implications for magnetic resonance imaging. Cell Tissue Res 2004;316:315–23
   PubMed Web of Science ®Google Scholar
• Gibaldi M, Perrier D. Pharmacokinetics, 2nd ed. Revised and expanded. New York: Marcel Dekker Inc.; 1982:433–44
   Google Scholar
• Briley-Sæbø K, Hustvedt SO, Haldorsen A, et al. Long-term imaging effects in rat liver after a single injection of an iron oxide nanoparticle based MR contrast agent. J Magn Reson Imaging 2004;20:622–31
   PubMed Web of Science ®Google Scholar
• Pouliquen D, Le Jeune JJ, Perdrisot R, et al. Iron oxide nanoparticles for use as an MRI contrast agent: pharmacokinetics and metabolism. Magn Reson Imaging 1991;9:215–83
   Web of Science ®Google Scholar
• Pouliquen D, Lucet I, Chouly C, et al. Liver-directed superparamagnetic iron oxide: quantitation of T2 relaxation effects. Magn Reson Imaging 1993;11:219–28
   PubMed Web of Science ®Google Scholar
• Taupitz M, Wagner S, Schnorr J, et al. Phase I clinical evaluation of citrate-coated monocrystalline very small superparamagnetic iron oxide particles as a new contrast medium for magnetic resonance imaging. Invest Radiol 2004;39:394–405
   Google Scholar
• Reimer P, Muller M, Marx C, et al. T1 effects of a bolus-injectable superparamagnetic iron oxide, SH U 555 A: dependence on field strength and plasma concentration-preliminary clinical experience with dynamic T1-weighted MR imaging. Radiology 1998;209:831–6
   PubMed Web of Science ®Google Scholar
• Na JB, Suh JS, Huh YM, et al. Pharmacokinetic modeling of phagocytic activity of the liver using superparamagnetic iron oxide nanoparticles in dynamic MR imaging. Yonsei Med J 2003;44:429–37
   PubMed Web of Science ®Google Scholar
• Bjørnerud A, Johansson L. The utility of superparamagnetic contrast agents in MRI: theoretical consideration and applications in the cardiovascular system. NMR Biomed 2004;17:465–77
   PubMed Web of Science ®Google Scholar
• Brillet PY, Gazeau F, Luciani A, et al. Evaluation of tumoral enhancement by superparamagnetic iron oxide particles: comparative studies with ferumoxtran and anionic iron oxide nanoparticles. Eur Radiol 2005;15:1369–77
   PubMed Web of Science ®Google Scholar
• Kato N, Takahashi M, Tsuji T, et al. Dose-dependency and rate of decay of efficacy of Resovist on MR images in a rat cirrhotic liver model. Invest Radiol 1999;34:551–7
   PubMed Web of Science ®Google Scholar
• Bengele HH, Palmacci S, Rogers J, et al. Biodistribution of an ultrasmall superparamagnetic iron oxide colloid BMS 180549 by different routes of administration. Magn Reson Imaging 1994;12:433–42
   PubMed Web of Science ®Google Scholar
• Van Beers BE, Sempoux C, Materne R, et al. Biodistribution of ultrasmall iron oxide particles in the rat liver. J Magn Reson Imaging 2001;13:594–9
   PubMed Web of Science ®Google Scholar
• Owens DE, Peppas NA. Opsonization, biodistribution, and pharmacokinetics of polymeric nanoparticles. Int J Pharm 2006;307:93–102
   PubMed Web of Science ®Google Scholar
• Majumdar S, Zoghbi S, Gore JC. The influence of pulse sequence on the relaxation effects of superparamagnetic iron oxide contrast agents. Magn Reson Med 1989;10:289–301
   PubMed Web of Science ®Google Scholar
• Réty F, Clément O, Siauve N, et al. MR lymphography using iron oxide nanoparticles in rats: pharmacokinetics in the lymphatic system after intravenous injection. J Magn Reson Imaging 2000;12:734–9
   PubMed Web of Science ®Google Scholar
• Briley-Saebo KC, Johansson LO, Hustvedt SO, et al. Clearance of iron oxide particles in rat liver effect of hydrated particle size and coating material on liver metabolism. Invest Radiol 2006;41:560–71
   PubMed Web of Science ®Google Scholar
• Bennett KM, Shapiro EM, Sotak CH, et al. Controlled aggregation of ferritin to modulate MRI relaxivity. Biophys J 2008;95:342–51
   PubMed Web of Science ®Google Scholar
• Martina MS, Fortin JP, Ménager C, et al. Generation of superparamagnetic liposomes revealed as highly efficient MRI contrast agents for in vivo imaging. J Am Chem Soc 2005;127:10676–85
   PubMed Web of Science ®Google Scholar
• Josephson L, Lewis J, Jacobs P, et al. The effects of iron oxides on proton relaxivity. Magn Reson Imaging 1988;6:647–53
   PubMed Web of Science ®Google Scholar
• Berret JF, Schonbeck N, Gazeau F, et al. Controlled clustering of superparamagnetic nanoparticles using block copolymers: design of new contrast agents for magnetic resonance imaging. J Am Chem Soc 2006;128:1755–61
   PubMed Web of Science ®Google Scholar
• Ai H, Flask C, Weinberg B, et al. Magnetite-loaded polymeric micelles as ultrasensitive magnetic-resonance probes. Adv Mater 2005;17:1949–52
   Web of Science ®Google Scholar